Springer Nature Staff
Events

Nature Conferences | Next Generation Cancer Therapeutics

The Next Generation Cancer Therapeutics conference will be held on the 6-8 October 2026 in Houston, Texas, USA! It will bring together leading researchers from academia, biotechnology and the pharmaceutical industry to discuss emerging strategies transforming the landscape of cancer therapeutics.

Published in Cancer and Pharmacy & Pharmacology

Go to the profile of Alice Taylor
Alice Taylor
Communities Manager - Medicine and Life Sciences, Springer Nature
Nature Conferences | Next Generation Cancer Therapeutics
Like
Go to the profile of Leilei Shi

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

Share with...

...or copy the link

This is a representation of how your post may appear on social media. The actual post will vary between social networks

 

Date
October 6-8, 2026
 Location
Houston, Texas, USA
 Format
In-Person Event
  
 
To register and submit an abstract, please visit  Next Generation Cancer Therapeutics 🧫

 

Registration open until October 5, 2026. Abstract deadline August 7, 2026. 
 
This conference will bring together leading researchers from academia, biotechnology and the pharmaceutical industry to discuss emerging strategies that are transforming the landscape of cancer therapeutics. We will highlight advances in the development of next-generation treatment modalities and the technologies that are enabling them.
  
Talks will cover next-generation biologics and immunotherapies, such as T-cell engagers, cancer vaccines, in vivo CAR approaches, oncolytic virotherapy and microbiome-based therapies. We will also explore new paradigms in targeted protein modulation, including molecular glues, PROTACs and RNA degraders, as well as emerging targeted therapies for historically challenging oncogenic drivers such as RAS.
  
In addition, we will address innovative therapeutic platforms and engineering approaches, including nanotechnology-based therapeutics, engineered bacteria and next-generation tumour models. Finally, we will examine how artificial intelligence is accelerating therapeutic development through AI-assisted drug design and screening, biomarker-guided therapy identification and patient stratification, agentic AI systems and foundation models.
  
Starting on the morning of Tuesday October 6 and concluding in the early afternoon of Thursday October 8, the conference will include talks from approximately 23 invited speakers, short talks selected from submitted abstracts and poster sessions.
 
Conference sessions will focus on the following themes:
 
• Next-generation biologics
• Next-generation immunotherapy
• Next-generation targeted therapies
• Next-generation therapeutic platforms
• Artificial intelligence in therapeutics
 
 

Keynote speakers: 

 
Christina Curtis Paul Workman
Christina Curtis

RZ Cao Professor of Medicine, Genetics & Biomedical Data Science

Stanford University

(California, USA)
Paul Workman

Harrap Professor of Pharmacology and Therapeutics

The Institute of Cancer Research

(London, United Kingdom)
 
 For more information, please visit  Next Generation Cancer Therapeutics 🧫
 

Go to the profile of Alice Taylor
Alice Taylor (She/Her)
Communities Manager - Medicine and Life Sciences, Springer Nature

Helping researchers connect, collaborate, and communicate their work. Specialising in Medicine and Life Science and passionate about making science more visible and accessible.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Sign In Register

Cookies

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website. You can decide for yourself which categories you want to deny or allow. Please note that based on your settings not all functionalities of the site are available.

Further information can be found in our privacy policy.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.